Interaction of arylpiperazines with the dopamine receptor D2 binding site. 2005

Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
Centre for Chemistry, Institute for Chemistry, Technology and Metallurgya, Belgrade, Serbia and Montenegro.

The docking of several 1-benzyl-4-arylpiperazines to the dopamine receptor (DAR) D2 was examined. The results demonstrated that the interaction of protonated N1 of the piperazine ring with Asp 86 (III.32) and edge-to-face interactions of the aromatic ring of the arylpiperazine part of the ligand with Phe 178 (VI.44), Trp 182 (VI.48) and Tyr 216 (VII.58) of the receptor, represent the major stabilizing forces. Besides, the hydrogen bond acceptor group in position 2 of the phenylpiperazine aromatic ring could build one more hydrogen bond with Trp 182 (VI.48). Bulky substituents in position 4 were not tolerated due to the unfavorable sterical interaction with Phe 178 (VI.44). Substituents in position 2 and 3 were found to be sterically well tolerated. Introduction of electron attractive -NO2 group in position 3 of aryipiperazines decreased, while electron donors (-OMe) and the second aromatic ring (naphthyl) increased the binding affinity comparing to that of the phenylpiperazine 1. This can be explained in terms of favoured edge-to-face interactions in ligands with a high negative electrostatic surface potential (ESP) in the centre of aromatic residue of arylpiperazines. Thus, besides the salt bridges and hydrogen bonds, edge-to-face interactions significantly contribute to arylpiperazine ligands to form complexes with the DAR D2. Phe 178 (VI.44), Trp 182 (VI.48) and Tyr 216 (VII.58) can be considered as a part of the ancillary DAR D2 pocket preserved in most G protein-coupled receptors of the A class and obviously, the arylpiperazine structural motif represents one of the privileged structures that bind to this pocket.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002627 Chemistry, Physical The study of CHEMICAL PHENOMENA and processes in terms of the underlying PHYSICAL PHENOMENA and processes. Physical Chemistry,Chemistries, Physical,Physical Chemistries
D000478 Alkylation The covalent bonding of an alkyl group to an organic compound. It can occur by a simple addition reaction or by substitution of another functional group. Alkylations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013055 Spectrophotometry, Infrared Spectrophotometry in the infrared region, usually for the purpose of chemical analysis through measurement of absorption spectra associated with rotational and vibrational energy levels of molecules. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) IR Spectra,Infrared Spectrophotometry,IR Spectras,Spectra, IR
D013574 Synaptosomes Pinched-off nerve endings and their contents of vesicles and cytoplasm together with the attached subsynaptic area of the membrane of the post-synaptic cell. They are largely artificial structures produced by fractionation after selective centrifugation of nervous tissue homogenates. Synaptosome

Related Publications

Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
January 2006, Biochemical and biophysical research communications,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
June 1991, The Japanese journal of psychiatry and neurology,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
April 2013, Journal of molecular modeling,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
August 2008, Molecular pharmacology,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
January 2004, Proceedings of the National Academy of Sciences of the United States of America,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
August 2021, Molecular pharmacology,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
August 2009, Synapse (New York, N.Y.),
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
October 1992, European journal of pharmacology,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
January 1993, General pharmacology,
Vladimir Sukalović, and Mario Zlatović, and Deana Andrić, and Goran Roglić, and Sladjana Kostić-Rajacić, and Vukić Soskić
May 2009, Cephalalgia : an international journal of headache,
Copied contents to your clipboard!